|Year : 2021 | Volume
| Issue : 1 | Page : 114-118
Effect of intracuff dexamethasone on incidence and severity of post operative sore -Prospective randomized study
Sunil Rajan, Naina Narayani, Jerry Paul, Lakshmi Kumar
Department of Anaesthesiology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India
|Date of Submission||04-Feb-2019|
|Date of Acceptance||05-Sep-2019|
|Date of Web Publication||10-Apr-2021|
Dr. Sunil Rajan
Department of Anaesthesiology, Amrita Institute of Medical Sciences, Kochi, Kerala
Source of Support: None, Conflict of Interest: None
Background and Aims: Postoperative sore throat (POST) continues to be a common concern following endotracheal intubation. Objectives of the present study were to compare the effects of intracuff dexamethasone on the incidence and severity of POST, postoperative hoarseness of voice (POHV) and cough (POC).
Material and Methods: This prospective, randomized, double blinded study was conducted in 60 patients undergoing short laparoscopic surgery lasting <2 h. Patients were randomly allocated into Group A and B. After intubation, endotracheal tube (ETT) cuffs were filled with saline in group A and with 0.1 mg/kg dexamethasone in group B. All patients received general anesthesia as per a standardized protocol. Incidence and severity of POST, POC, and POHV were assessed.
Results: As compared to group A, the number of patients who had sore throat was significantly low in group B at 2, 6, 12, and 24 h (P < 0.001). Though more number of patients in group A had postop cough at all time points and postop hoarseness of voice at 2,6, and 12 h, the difference was statistically significant only at 2 h and 6 h for both. Severity as well as the incidence of POST, POC, and POHV showed a downward trend in both groups with time. In group B, no patient had POST after 12 h, POC after 6 h, and none complained of POHV in the postoperative period.
Conclusion: Intracuff dexamethasone 0.1 mg/kg significantly reduces incidence and severity of POST, POC, and POHV which occur following general anesthesia with endotracheal intubation in patients undergoing short pelvic laparoscopic procedures lasting <2 h.
Keywords: Cough, dexamethasone, hoarseness, postoperative, sore throat
|How to cite this article:|
Rajan S, Narayani N, Paul J, Kumar L. Effect of intracuff dexamethasone on incidence and severity of post operative sore -Prospective randomized study. J Anaesthesiol Clin Pharmacol 2021;37:114-8
|How to cite this URL:|
Rajan S, Narayani N, Paul J, Kumar L. Effect of intracuff dexamethasone on incidence and severity of post operative sore -Prospective randomized study. J Anaesthesiol Clin Pharmacol [serial online] 2021 [cited 2021 Jun 25];37:114-8. Available from: https://www.joacp.org/text.asp?2021/37/1/114/313422
| Background|| |
Ever since the adoption of endotracheal intubation into anesthesia practice, concerns regarding postoperative sore throat (POST) began, which continues till date. Although it is a self-limiting condition, it may delay discharge after day care surgeries. The incidence of POST can be as high as 45.4% following intubation and the common predictors are airway management, female sex, younger patients, gynecological surgeries, and succinylcholine.
Many modalities of intervention have been tried to prevent its development, but not all yielded promising results. Of late, studies have shown that use of intracuff dexamethasone can be an be effective method in reducing postoperative pharyngo-laryngeal complications.,, The primary objective of the present study was to compare the effect of intracuff dexamethasone on the incidence and severity of POST. The secondary objectives included comparison of the effect on postoperative hoarseness of voice (POHV) and cough (POC).
| Material and Methods|| |
This prospective, randomized, double blinded study was conducted after obtaining hospital ethical committee clearance and patients' consent. The study was registered in Clinical Trial Registry of India (CTRI/2019/01/016992). Sixty patients aged 18 years to 60 years with American Society of Anesthesiologists (ASA) Physical status 1-2 undergoing short laparoscopic surgery lasting less than 2 h like diagnostic pelvic laparoscopy and laparoscopic sterilization were included in the study. While those who required nasogastric tube insertion, three or more attempts at laryngoscopy or bougie for intubation were excluded from the study. Those who sustained trauma while intubation or nasogastric tube insertion as evidenced by blood on cuff after extubation or blood stained secretions while suctioning before extubation, MP score of 3, 4, those with preoperative sore throat (edema/inflammation noticed during laryngoscopy) or already on analgesics or steroids (systemic or inhaled) and hoarseness of voice or respiratory infection were also excluded.
Patients were randomly allocated into Group A and B with 30 patients in each group who received intracuff saline and 0.1 mg/kg of dexamethasone, respectively. Randomization was done using computer generated random sequence of numbers and allocation concealment was ensured using sequentially numbered opaque-sealed envelopes.
All patients received general anesthesia as per a standardized protocol. They were preoxygenated with 100% oxygen for 3 min followed by intravenous glycopyrrolate 0.2 mg, midazolam 1 mg, and fentanyl 2 μg/kg. Patients were induced with propofol 1.5 to 2.5 mg/kg and were mask ventilated with isoflurane 1% in oxygen. Vecuronium 0.1 mg/kg IV was administered after induction, and 3 min later, the patients were intubated following a gentle and quick laryngoscopy lasting not more than 15 s with a low-pressure, high-volume cuffed poly vinyl chloride endotracheal tube (ETT). In male and female patients, 8 mm and 7 mm internal diameter tubes were used, respectively. All intubations were performed by the same anesthesiologist and were confirmed with bilateral air entry on auscultation and appearance of regular end tidal capnographic waveform. ETT cuffs were filled with minimal volume of test solution required to prevent a leak audible to ear. In group B, the calculated dose of dexamethasone was initially injected to ETT cuff followed by required volume of saline.
Anesthesia was maintained using oxygen in air (1:2) with 1–1.2% isoflurane (end tidal, 0.7 to 1 MAC) and intermittent positive pressure ventilation maintaining endtidal carbon dioxide levels at 30–35 mm Hg. Vecuronium 0.05 mg/kg was repeated at 30-min interval to provide muscle relaxation. Paracetamol 1 gm was intravenously administered half an hour after induction. Rise in heart rate and/or mean arterial pressure more than 20% from the baseline value was initially treated with increasing the inspired concentration of isoflurane to 1.5–2% transiently. If not responding, fentanyl was repeated at 0.5 ug/kg as boluses.
At the end of surgery, ondansetron 0.1 mg/kg was given intravenously and the residual muscle paralysis was reversed with neostigmine 0.05 to 0.07 mg/kg and glycopyrrolate 10 μg/kg IV. Extubation was performed following gentle oro-pharyngeal suctioning. Postoperatively all patients received paracetamol 1 gm at 8-h interval and tramadol 1.5 mg/kg on demand intravenously. If this failed to control surgical site pain, intravenous fentanyl 0.5 ug/kg incremental boluses were given. Total perioperative opioid consumption and duration of intubation were also documented.
POST, POHV, and POC were assessed at 2, 6, 12, and 24 h based on the scales described in [Table 1], by a nursing staff in the postoperative care unit who was unaware of the intervention performed intraoperatively. The patients were also blinded to the type of solution used to fill the cuff. Those with grade III sore throat were managed with dispersible Aspirin 75 mg gargle, which was repeated as many times as needed till there was relief from the symptoms.
|Table 1: Assessment of severity of postoperative sore throat, cough, and hoarseness of voice|
Click here to view
As there was no similar study published in the past with the dose of the test drug we intended to use, we conducted a pilot study with 20 patients in two groups with one group receiving intracuff dexamethasone and the other saline. Incidence of POST at 2 h was found to be 10% in dexamethasone group as compared to 55% in saline group. Based on this result with 99% power and 20% error, sample size was calculated as 26 per group using the formula n = (Zα/2 + Zβ)2× [P1 (1 − P1) + P2 (1 − P2)] ÷ (P1 − P2)2. However, we recruited a total of 60 patients in our study.
Pearson's Chi-square test or Fisher's exact test was used to compare categorical variables such as distribution of gender, Mallampatti score and ASA physical status, number of attempts at intubation as well as incidence, and severity of POST, POHV, and POC. Independent sample t-test was used to compare continuous variables such as age, weight, intraoperative opioid consumption, and duration of intubation among the groups. Statistical analyses were performed using SPSS Version 20.0 for Windows (IBM Corporation ARMONK, NY, USA).
| Results|| |
Both groups were comparable with respect to mean age and weight, distribution of sex, ASA physical status, and Mallampatti score. Both group A and B had comparable intraoperative fentanyl consumption. However, the duration of intubation was significantly longer in Group B (114.4 ± 3.04 vs. 105.03 ± 10.85 min, P = <0.001, [Table 2]).
|Table 2: Comparison of demographics, ASA physical status, Mallampatti score, intraoperative fentanyl consumption, and duration of intubation|
Click here to view
While comparing the presence or absence of postop sore throat, hoarseness of voice, and cough among the groups, it was found that compared to group A, the number of patients who had sore throat was significantly low in group B at 2, 6, 12, and 24 h (P < 0.001). Although more patients in group A had postop cough at all time points and postop hoarseness of voice at 2, 6, and 12 h, the difference was statistically significant only at 2 h and 6 h for both [Table 3]. Severity as well as the incidence of POST showed a downward trend in both groups with time [Figure 1]. Similar trend was seen with hoarseness of voice and cough as well [Figure 2] and [Figure 3].
|Table 3: Comparison of incidence of postop sore throat, cough, and hoarseness of voice|
Click here to view
| Discussion|| |
In the present study, it was observed that incidence and severity of POST, POHV, and POC were significantly lower when ETT cuffs were filled with dexamethasone. In this group, no patient had POST after 12 h, POC after 6 h, and none complained of POHV.
Endotracheal intubation imparts safety by protecting the airway, but with a higher risk of postoperative sore throat. The proposed mechanisms include an aseptic inflammatory process caused by irritation of the pharyngeal mucosa during laryngoscopy, and continued irritation of tracheal mucosa due to the presence of ETT cuff. Another major contributing factor is trauma that might occur during laryngoscopy and intubation.,, Various drugs and routes of administration have been tried to prevent and treat POST.
Steroids continue to play a major role in preventing and managing these post-extubation respiratory complications. Betamethasone gel, budesonide inhalation, intravenous dexamethasone, and hydrocortisone have proven their efficacy in this regard. A meta-analysis of seven RCTs have shown that intravenous dexamethasone reduces the risk and severity of POST, the effective dosage being over 0.1 mg/kg. The potential mechanism of intracuff dexamethasone is presumably based on its anti-inflammatory activity, which includes inhibition of leukocyte migration, maintenance of cell membrane integrity, attenuation of lysosome release, and reduction of fibroblast proliferation.
Anesthetic gases and lipophilic drugs diffuse through ETT cuff by permeation. It is a three-step process: adsorption onto the polymer, diffusion across the bulk of the polymer, and desorption on to the tracheal mucosa. Only minute amount of drug diffuses across the cuff and exert anti-inflammatory action on the mucosa. Although perioperative single-dose dexamethasone was not found to be associated with the increased risk of infection or delayed wound healing, it results in slight hyperglycemia on the first postoperative day. When it is used inside the ETT cuff, the chance of developing even this side effect becomes minimal.
Use of nitrous oxide during general anesthesia is shown to increase intracuff pressure and results in an increased incidence of POST when cuff is filled with air. This is because nitrous oxide diffuses into air-filled cuff faster than nitrogen can escape from it, leading to increase in volume and, subsequently, pressure inside cuff. Filling an ETT cuff with a liquid possibly prevents rise in intracuff pressures intraoperatively., The reason for the relatively stable cuff pressure with liquid media is liquids do not expand when gases dissolve in them. The mean number of cuff deflations required to maintain baseline intracuff pressure was found to be less when liquid media was used to inflate ETT cuff during general anesthesia. This could have also contributed to lesser incidence and severity of the postoperative pharyngolaryngeal complications observed in our study.
Few studies have tested the efficacy of intracuff steroids on attenuating POST. Rafiei et al. investigated the effect of intracuff dexamethasone and concluded that it was effective in reducing the severity of POC and not effective in reducing the incidence or severity of POST and POHV. Conflicting results were observed by Choubsaz et al. who found that inflating ETT cuff with dexamethasone 4 mg did not reduce POST. However, in our study, we observed a reduction in POST with intracuff dexamethasone. This could be because we used a higher concentration of dexamethasone like 0.1 mg/kg, whereas in the study by Choubsaz et al. a fixed dose of 4 mg was used to inflate the cuff irrespective of body weight. The study by Desai et al. had showed that intracuff alkalinized lignocaine and dexamethasone were better than saline in preventing POST and POC. In their study, intracuff dexamethasone group had shown to have higher incidence of hoarseness of voice even though they used 8-mg dexamethasone in the cuff. Another study by Sugathan et al. showed that intracuff dexamethasone 8 mg reduced the incidence of POST and POC as compared to intracuff normal saline but not postoperative hoarseness of voice.
The duration of intubation was significantly longer in Group B (114.4 ± 3.04 vs. 105.03 ± 10.85 min) in our study. However, postoperative laryngopharyngeal complications were less in that group. This observation is also in favor of efficacy of intracuff dexamethasone in attenuating POST, POC, and POHV. The mean difference in the duration of intubation, approximately by 10 min, though statistically significant, may not have any clinical relevance.
The strong points of our study were that all the intubations were performed by a single anesthesiologist, which eliminated subjective differences due to experience and skill. We have included only patients undergoing short pelvic laparoscopic surgeries in our study because postoperative pain in these patients would be minimal so that appreciation of POST would not get affected. In our study the same degree of tilt was given for all cases. So ETT migration in both groups would have been uniform thereby eliminating any bias due to different degrees of table tilt. The major drawback of our study was that we were not able to measure the intracuff pressure because fluid would enter the manometer and damage the equipment. We used minimal volume of fluid required to prevent an audible leak to fill the cuff; therefore, the intracuff pressures might not have been uniform in all the cases. The number of times aspirin gargle was used to control POST was not recorded.
| Conclusion|| |
Intracuff dexamethasone 0.1 mg/kg significantly reduces the incidence and severity of postoperative sore throat, hoarseness of voice, and cough which occur following general anesthesia with endotracheal intubation in patients undergoing short pelvic laparoscopic procedures lasting less than 2 h.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Higgins PP, Chung F, Mezei G. Postoperative sore throat after ambulatory surgery. BJA 2002;88:582-4.
Rafiei MR, Arianpour N, Rezvani M, Ebrahimi A. Effects of intracuff dexamethasone on post extubation reactions. J Res Med Sci 2012;17:338-43.
Desai T, Bhat Pai RV, Kambli D, Dias ES, Kamat SS. Effects of intracuff alkalinized lignocaine, dexamethasone, or normal saline on endotracheal tube-induced emergence phenomena: A randomized double-blinded study. Indian Anaesth Forum 2019;20:9-15. [Full text]
Sugathan R, Raj S. Efficacy of intracuff dexamethasone in reducing the incidence of post-operative sore throat: An original article. Int J Res Med Sci 2019;7:1665-9.
Park SH, Hang SH, Do SH, Kim JW, Rhee KY, Kim JH. Prophylactic dexamathasone decreases the incidence of sore throat and hoarseness after tracheal extubation with a double lumen endotracheal tube. Anesth Analg 2008;107:1814-8.
Chan L, Lee ML, Lo YL. Postoperative sore throat and ketamine gargle. Br. J. Anaesth 2010;105:97.
Huang YS, Hung NK, Lee MS, Kuo CP, Yu JC, Huang GS, et al
. The effectiveness of benzydamine hydrochloride spraying on the endotracheal tube cuff or oral mucosa for postoperative sore throat. Anesth Analg 2010;111:887-91.
Rudra A, Ray S, Chatterjee S, Ahmed A, Ghosh S. Gargling with ketamine attenuates the postoperative sore throat. Indian J Anaesth 2009;53:40-3.
] [Full text]
Fayyaz A, Furqan A, Ammar A, Akhtar R. Comparing the effectiveness of Betamethasone Gel with Lidocaine Gel local application on endotracheal tube in preventing post-operative sore throat (POST). J Pak Med Assoc 2017;67:873-6.
Rajan S, Tosh P, Paul J, Kumar L. Effect of inhaled budesonide suspension, administered using a metered dose inhaler, on post-operative sore throat, hoarseness of voice and cough. Indian J Anaesth 2018;62:66-71.
] [Full text]
Bagchi D, Mandal MC, Das S, Sahoo T, Basu SR, Sarkar S. Efficacy of intravenous dexamethasone to reduce incidence of postoperative sore throat: A prospective randomized controlled trial. J Anaesthesiol Clin Pharmacol 2012;28:477-80.
] [Full text]
Eydi M, Kolahdouzan K, Golzari SEJ. Effect of intravenous hydrocortisone on preventing postoperative sore throat followed by Laryngeal Mask Airway use in patients undergoing urogenital surgeries. J Cardiovasc Thorac Res 2013;5:29-33.
Sun L, Guo R, Sun L. Dexamethasone for preventing postoperative sore throat: A meta-analysis of randomized controlled trials. Ir J Med Sci 2014;183:593-600.
Dollo G, Estebe JP, Corre PL, Chevanne F, Ecoffey C, Verge RL. Endotracheal tube cuffs filled with lidocaine as a drug delivery system: In vitro
and in vivo
investigations. Eur J Pharm Sci 2001;13:319-23.
Waldron NH, Jones CA, Gan TJ, Allen TK, Habib AS. Impact of perioperative dexamethasone on postoperative analgesia and side-effects: Systematic review and meta-analysis. Br J Anaesth 2013;110:191-200.
Maruyama K, Sakai H, Miyazawa H, Toda N, Iinuma Y, Mochizuki N, et al
. Sore throat and hoarseness after total intravenous anaesthesia. Br J Anaesth 2004;92:541-3.
Singh M, Malhotra N, Malhotra S. Tracheal morbidity following tracheal intubation: Comparison of air, saline and lignocaine used for inflating cuff. J Anaesthesiol Clin Pharmacol 2007;23:163-7. [Full text]
Soltani HA, Aghadavoudi O. The effect of different lidocaine application methods on postoperative cough and sore throat. J Clin Anesth 2002;14:15-8.
Higgins PP, Chung F, Mezei G. Postoperative sore throat after ambulatory surgery. Br J Anaesth 2002;88:582-4.
Budania LS, Chamala V, Rao M, Virmani S, Goyal KA, Nanda K. Effect of air, anesthetic gas mixture, saline, or 2% lignocaine used for tracheal tube cuff inflation on coughing and laryngotracheal morbidity after tracheal extubation. J Anaesthesiol Clin Pharmacol 2018;34:386-91.
] [Full text]
Choubsaz M, Amirifard N, Sadeghi M, Sadeghi E, Johari Z. The effect of adding dexamethasone to intracuff lidocaine 2% on decreasing the respiratory complications after general anesthesia: A randomized, double blind, clinical trial. J App Pharm Sci 2016;6:152-5.
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2], [Table 3]